Perspectives on Biomarker and Surrogate Endpoint Evaluation : Discussion Forum Summary.
Material type:
- text
- computer
- online resource
- 9780309163255
- R853.B54 -- M33 2011eb
FrontMatter -- Reviewers -- Contents -- 1 Introduction -- 2 Committee Findings and Recommendations -- 3 FDA Perspectives -- 4 National Institutes of Health Perspectives -- 5 Industry Perspectives -- 6 Public Health, Consumer, and Consulting Organization Perspectives -- 7 Presentation by Thomas Fleming: Biomarkers and Surrogate Endpoints in Chronic Disease -- 8 Key Themes, Challenges, and Opportunities -- 9 Importance of the Biomarker Discussion Forum -- References -- Acronyms -- Glossary -- Appendix A: Discussion Forum Agenda -- Appendix B: Summary from the Committee's Report *Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease*.
Description based on publisher supplied metadata and other sources.
Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.
There are no comments on this title.